DOI: https://doi.org/10.36347/sasjs.2026.v12i05.032

Pages: 514-522

Background: Eyelid tumors represent approximately 15% of all facial skin carcinomas. Their management requires a multidisciplinary approach combining oncology and reconstructive surgery. Objective: To describe the epidemiological, clinical, and therapeutic profile of patients with eyelid tumors in a Moroccan university hospital center. Methods: A retrospective descriptive study conducted at the Department of Reconstructive, Plastic, Aesthetic Surgery and Burns of Mohammed VI University Hospital Center in Tangier-Tetouan-Al Hoceima, over a 24-month period (April 2021 - March 2023). Demographic, clinical, histological, and therapeutic data from 28 patients were analyzed. Results: The mean age was 62.37 years (range: 8-80 years), with male predominance (sex ratio = 1.8). The majority of patients (67.86%) came from rural areas. Sun exposure was found in 100% of patients. The mean diagnostic delay was 18 months. Basal cell carcinoma dominated histology (75%), followed by adenoid cystic carcinoma (17.86%). The upper eyelid was affected in 75% of cases. Surgery was the treatment of choice: direct sutures (35.71%), temporal flap (50%), Mustarde flap (7.14%). Orbital exenteration was required in 50% of cases. External radiotherapy supplemented surgery in 7 patients. No chemotherapy was administered. Conclusion: Basal cell carcinoma remains the most frequent eyelid tumor in our series. Diagnostic delay remains concerning. Reconstructive surgery, particularly using flaps, allows satisfactory functional and aesthetic restoration. Increased awareness and early screening are essential.